118 related articles for article (PubMed ID: 35984205)
21. Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
Shao Y; Sun X; He Y; Liu C; Liu H
PLoS One; 2015; 10(7):e0133830. PubMed ID: 26207909
[TBL] [Abstract][Full Text] [Related]
22. Core Needle Biopsy Accuracy for Androgen Receptor Expression in Invasive Breast Cancer.
Santos MMD; Frasson AL; Silva VDD; Maciel ACA; Watte G; Werutsky G; Reinert T; Fay AP
Rev Bras Ginecol Obstet; 2023 Sep; 45(9):e535-e541. PubMed ID: 37846186
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor status is highly conserved during tumor progression of breast cancer.
Grogg A; Trippel M; Pfaltz K; Lädrach C; Droeser RA; Cihoric N; Salhia B; Zweifel M; Tapia C
BMC Cancer; 2015 Nov; 15():872. PubMed ID: 26552477
[TBL] [Abstract][Full Text] [Related]
24. Expression levels and clinical values of miR-92b-3p in breast cancer.
Du Y; Miao Z; Wang K; Lv Y; Qiu L; Guo L
World J Surg Oncol; 2021 Aug; 19(1):239. PubMed ID: 34380511
[TBL] [Abstract][Full Text] [Related]
25. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
Takeda M; Sakuragi N; Okamoto K; Todo Y; Minobe S; Nomura E; Negishi H; Oikawa M; Yamamoto R; Fujimoto S
Acta Obstet Gynecol Scand; 2002 May; 81(5):451-7. PubMed ID: 12027820
[TBL] [Abstract][Full Text] [Related]
26. [Preoperative serum CA15.3 and CEA levels and clinical-biological parameters in breast tumors].
Ruibal A; Garrido Pumar M; Arias JI
Rev Esp Med Nucl; 2006; 25(3):180-3. PubMed ID: 16762272
[TBL] [Abstract][Full Text] [Related]
27. Relationship between tumor markers CEA and CA 15-3, TNM staging, estrogen receptor rate and MIB-1 index in patients with pT1-2 breast cancer.
Lumachi F; Basso SM; Brandes AA; Pagano D; Ermani M
Anticancer Res; 2004; 24(5B):3221-4. PubMed ID: 15510614
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of androgen receptors in breast cancer subtypes.
Kraby MR; Valla M; Opdahl S; Haugen OA; Sawicka JE; Engstrøm MJ; Bofin AM
Breast Cancer Res Treat; 2018 Nov; 172(2):283-296. PubMed ID: 30109519
[TBL] [Abstract][Full Text] [Related]
29. The prognostic significance of LIAISON(R) CA15-3 assay in primary breast cancer.
Nisman B; Maimon O; Allweis T; Kadouri L; Maly B; Hamburger T; Peretz T
Anticancer Res; 2013 Jan; 33(1):293-9. PubMed ID: 23267160
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the Diagnostic and Predicative Values of 8-Iso-Prostaglandin F2α as a Biomarker of Breast Cancer.
Nour Eldin EEM; Nour Eldein MM; El-Readi MZ; Mirza AA; Fatani SH; Al-Amodi HS; Althubiti MA; Al-Ezzi EM; Eid SY; Kamel HFM
Oncol Res Treat; 2020; 43(10):506-517. PubMed ID: 32721979
[TBL] [Abstract][Full Text] [Related]
31. Correlation of microRNA-367 in the clinicopathologic features and prognosis of breast cancer patients.
Liu B; Pan J; Fu C
Medicine (Baltimore); 2021 Jun; 100(22):e26103. PubMed ID: 34087856
[TBL] [Abstract][Full Text] [Related]
32. High serum exosomal long non-coding RNA DANCR expression confers poor prognosis in patients with breast cancer.
Shi W; Jin X; Wang Y; Zhang Q; Yang L
J Clin Lab Anal; 2022 Mar; 36(3):e24186. PubMed ID: 35150011
[TBL] [Abstract][Full Text] [Related]
33. 8-Hydroxy-2'-deoxyguanosine as a Discriminatory Biomarker for Early Detection of Breast Cancer.
Nour Eldin EEM; El-Readi MZ; Nour Eldein MM; Alfalki AA; Althubiti MA; Mohamed Kamel HF; Eid SY; Al-Amodi HS; Mirza AA
Clin Breast Cancer; 2019 Apr; 19(2):e385-e393. PubMed ID: 30683611
[TBL] [Abstract][Full Text] [Related]
34. Dual-Channel Detection of Breast Cancer Biomarkers CA15-3 and CEA in Human Serum Using Dialysis-Silicon Nanowire Field Effect Transistor.
Li H; Wang S; Li X; Cheng C; Shen X; Wang T
Int J Nanomedicine; 2022; 17():6289-6299. PubMed ID: 36536938
[TBL] [Abstract][Full Text] [Related]
35. Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival.
Okano M; Oshi M; Butash AL; Asaoka M; Katsuta E; Peng X; Qi Q; Yan L; Takabe K
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151151
[TBL] [Abstract][Full Text] [Related]
36. Impact of Androgen Receptor Expression and the AR:ER Ratio on the Survival Outcomes in the Diverse Subgroups of Vietnamese Breast Cancer: A Single Institutional Retrospective Cohort Analysis.
Phung HT; Nguyen CV; Mai NT; Vu HTN; Pham KH; Tran GL
Technol Cancer Res Treat; 2022; 21():15330338221080941. PubMed ID: 35379053
[No Abstract] [Full Text] [Related]
37. AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer.
Liu D
Cell Oncol (Dordr); 2020 Apr; 43(2):321-333. PubMed ID: 31933152
[TBL] [Abstract][Full Text] [Related]
38. Serum Human Epididymis Protein-4 (HE4) - A novel Approach to Differentiate Malignant Frombenign Breast Tumors.
Sai Baba KSS; Rehman MA; Pradeep Kumar J; Fatima M; Raju GSN; Uppin SG; Mohammed N
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2509-2507. PubMed ID: 34452565
[TBL] [Abstract][Full Text] [Related]
39. Assessment of circulating HISLA as a potential biomarker for breast cancer diagnosis and prognosis.
Hu H; Hu J; Yang Y; Zhou W; Ye C
Clin Exp Med; 2021 Feb; 21(1):29-34. PubMed ID: 33123839
[TBL] [Abstract][Full Text] [Related]
40. AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast Tumors.
Rangel N; Rondon-Lagos M; Annaratone L; Aristizábal-Pachon AF; Cassoni P; Sapino A; Castellano I
Cells; 2020 Apr; 9(4):. PubMed ID: 32344660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]